Long-term efficacy and safety of polyalkylimide gel for the treatment of HIV-associated lipoatrophy

References

• Duran , S. , Saves , M. , Spire , B. , Cailleton , V. , Sobel , A. Carrieri , P. 2001 . Failure to maintain long-term adherence to highly active antiretroviral therapy: The role of lipodystrophy . AIDS , 15 : 2441 – 2444 .
   PubMed Web of Science ®Google Scholar
• James , J. , Carruthers , A. and Carruthers , J. 2002 . HIV-associated facial lipoatrophy . Dermatologic Surgery , 28 : 979 – 986 .
   PubMed Web of Science ®Google Scholar
• Karim , R.B. , de Lint , C.A. , van Galen , S.R. , van Rozelaar , L. , Nieuwkerk , P.T. Askarizadeh , E. 2008 . Long-term effect of polyalkylimide gel injections on severity of facial lipoatrophy and quality of life of HIV-positive patients . Aesthetic Plastic Surgery , 32 : 873 – 878 .
   PubMed Web of Science ®Google Scholar
• Karim , R.B. , Hage , J.J. , van Rozelaar , L. , Lange , C.A. and Raaijmakers , J. 2006 . Complications of polyalkylimide 4% injections (Bio-Alcamid): A report of 18 cases . Journal of Plastic, Reconstructive & Aesthetic Surgery , 59 : 1409 – 1414 .
   PubMed Web of Science ®Google Scholar
• Lewis , V. and Finlay , A.Y. 2004 . 10 years experience of the Dermatology Life Quality Index (DLQI) . Journal of Investigative Dermatology, Symposium Proceedings of the Society for Investigative Dermatology and European Society for Dermatological Research , 9 : 169 – 180 .
   Web of Science ®Google Scholar
• Loutfy , M.R. , Raboud , J.M. , Antoniou , T. , Kovacs , C. , Shen , S. Halpenny , R. 2007 . Immediate versus delayed polyalkylimide gel injections to correct facial lipoatrophy in HIV-positive patients . AIDS , 21 : 1147 – 1155 .
   PubMed Web of Science ®Google Scholar
• Martin , A. and Mallon , P.W. 2005 . Therapeutic approaches to combating lipoatrophy: Do they work? . Journal of Antimicrobrial Chemotherapy , 55 : 612 – 615 .
   PubMed Web of Science ®Google Scholar
• Martin , A. , Smith , D.E. , Carr , A. , Ringland , C. , Amin , J. Emery , S. 2004 . Reversibility of lipoatrophy in HIV-infected patients 2 years after switching from a thymidine analogue to abacavir: The MITOX Extension Study . AIDS , 18 : 1029 – 1036 .
   PubMed Web of Science ®Google Scholar
• Moyle , G.J. , Brown , S. , Lysakova , L. and Barton , S.E. 2006 . Long-term safety and efficacy of poly-L-lactic acid in the treatment of HIV-related facial lipoatrophy . HIV Medicine , 7 : 181 – 185 .
   PubMed Web of Science ®Google Scholar
• Moyle , G.J. , Lysakova , L. , Brown , S. , Sibtain , N. , Healy , J. Priest , C. 2004 . A randomized open-label study of immediate versus delayed polylactic acid injections for the cosmetic management of facial lipoatrophy in persons with HIV infection . HIV Medicine , 5 : 82 – 87 .
   PubMed Web of Science ®Google Scholar
• Oette , M. , Juretzko , P. , Kroidl , A. , Sagir , A. , Wettstein , M. Siegrist , J. 2002 . Lipodystrophy syndrome and self-assessment of well-being and physical appearance in HIV-positive patients . AIDS Patient Care and STDS , 16 : 413 – 417 .
   PubMed Web of Science ®Google Scholar
• Pacini , S. , Ruggiero , M. , Morucci , G. , Cammarota , N. , Protopapa , C. and Gulisano , M. 2002 . Bio-Alcamid: A novelty for reconstructive and cosmetic surgery . Italian Journal of Anatomy and Embryology , 107 : 209 – 214 .
   PubMedGoogle Scholar
• Protopapa , C. , Sito , G. , Caporale , D. and Cammarota , N. 2003 . Bio-Alcamid™ in drug-induced lipodystrophy . Journal of Cosmetic and Laser Therapy , 5 : 226 – 230 .
   PubMedGoogle Scholar
• Savard , J. , Laberge , B. , Gauthier , J.G. , Ivers , H. and Bergeron , M.G. 1998 . Evaluating anxiety and depression in HIV-infected patients . Journal of Personality Assessment , 71 : 349 – 367 .
   PubMed Web of Science ®Google Scholar
• Sutinen , J. 2005 . Interventions for managing antiretroviral therapy-associated lipoatrophy . Current Opinion in Infectious Diseases , 18 : 25 – 33 .
   PubMed Web of Science ®Google Scholar
• Treacy , P.J. and Goldberg , D.J. 2006 . Use of a biopolymer polyalkylimide filler for facial lipodystrophy in HIV-positive patients undergoing treatment with antiretroviral drugs . Dermatologic Surgery , 32 : 804 – 808 .
   PubMed Web of Science ®Google Scholar
• Wu , A.W. , Revicki , D.A. , Jacobson , D. and Malitz , F.E. 1997 . Evidence for reliability, validity and usefulness of the Medical Outcomes Study HIV Health Survey (MOS-HIV) . Quality of Life Research , 6 : 481 – 493 .
   PubMed Web of Science ®Google Scholar